These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34374426)

  • 1. Global Experience With Rotavirus Vaccines.
    Burke RM; Tate JE; Parashar UD
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S792-S800. PubMed ID: 34374426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of rotavirus gastroenteritis and need of high rotavirus vaccine coverage with early completion of vaccination schedule for protection against rotavirus diarrhea in India: A narrative review.
    Raju B; Parikh RP; Vetter VV; Kolhapure S
    Indian J Public Health; 2019; 63(3):243-250. PubMed ID: 31552856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease.
    Glass RI; Tate JE; Jiang B; Parashar U
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S331-S342. PubMed ID: 34590142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
    Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccines: an overview.
    Dennehy PH
    Clin Microbiol Rev; 2008 Jan; 21(1):198-208. PubMed ID: 18202442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.
    Lepage P; Vergison A
    Expert Opin Biol Ther; 2007 Dec; 7(12):1881-92. PubMed ID: 18034653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
    Deen J; Lopez AL; Kanungo S; Wang XY; Anh DD; Tapia M; Grais RF
    Hum Vaccin Immunother; 2018 Feb; 14(2):495-499. PubMed ID: 29135339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1.
    Skansberg A; Sauer M; Tan M; Santosham M; Jennings MC
    Hum Vaccin Immunother; 2021 Apr; 17(4):1223-1234. PubMed ID: 33121329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rotavirus genetic diversity on vaccine impact.
    Sadiq A; Bostan N; Jadoon Khan ; Aziz A
    Rev Med Virol; 2022 Jan; 32(1):e2259. PubMed ID: 34997676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccines: safety, efficacy and public health impact.
    Gray J
    J Intern Med; 2011 Sep; 270(3):206-14. PubMed ID: 21668823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.
    Zaman K; Sack DA; Neuzil KM; Yunus M; Moulton LH; Sugimoto JD; Fleming JA; Hossain I; Arifeen SE; Azim T; Rahman M; Lewis KDC; Feller AJ; Qadri F; Halloran ME; Cravioto A; Victor JC
    PLoS Med; 2017 Apr; 14(4):e1002282. PubMed ID: 28419095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.
    Clark A; van Zandvoort K; Flasche S; Sanderson C; Bines J; Tate J; Parashar U; Jit M
    Lancet Infect Dis; 2019 Jul; 19(7):717-727. PubMed ID: 31178289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.
    Vetter V; Gardner RC; Debrus S; Benninghoff B; Pereira P
    Hum Vaccin Immunother; 2022 Dec; 18(1):1870395. PubMed ID: 33605839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus infection and the current status of rotavirus vaccines.
    Chen SC; Tan LB; Huang LM; Chen KT
    J Formos Med Assoc; 2012 Apr; 111(4):183-93. PubMed ID: 22526206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Immunity and acute viral gastroenteritis.
    Rose MA
    Hum Vaccin Immunother; 2014; 10(7):2112-4. PubMed ID: 25424826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.